Statement: MGI is committed to protecting its intellectual property assets on a global scale

/in , /by

MGI makes the following statement in response to Illumina’s patent litigation in the UK and Sweden: We believe these claims have no merit and are typical Illumina tactics intended to maintain a monopolistic market position and prevent choice from being offered to customers. We intend to vigorously defend ourselves, as we have in other jurisdictions. […]

Read more →

Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom

/in , /by

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000), DNBSeq-T7, and related chemistry reagents. The first complaint was filed against MGI Tech Co., Ltd. and Latvia MGI Tech SIA in the High Court of […]

Read more →

Lexogen Releases Scalable 12 nt Unique Dual Index System with Enhanced Error Correction for Multiplexing of up to 384+ RNA-Seq Libraries

/in , , , , , /by

Vienna, Austria – The massive output of modern short-read next generation sequencing (NGS) platforms allows to multiplex hundreds of samples to be processed in one NGS run. Each sample is identified by adding a unique index sequence to an NGS library, ensuring these libraries can be mixed and sequenced collectively. This system reduces sequencing costs […]

Read more →

ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests

/in , /by

Co-marketing partnership to drive awareness of ArcherDX IVD products and increase access to vital genomic information in the community oncology care setting Boulder, Colorado – ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ILMN) intended to broaden access of next generation sequencing (NGS)-based oncology testing, including companion diagnostics for therapeutic selection, personalized […]

Read more →

ReadCoor, Inc. Announces $27 Million Series B Financing for Commercial Launch of 3D RNA, DNA, and Protein Spatial Sequencing Platform

/in , , , /by

ReadCoor’s technology simultaneously detects hundreds to thousands of RNA, DNA, proteins, and therapeutics in every cell within intact tissue Spatially surveying thousands of molecules simultaneously drives meaningful insights into disease states and treatment effects Spatial analysis across multiple omic formats gives researchers new insights into cancer, immuno-oncology, gene therapy, and neurodegenerative diseases CAMBRIDGE, Mass., January […]

Read more →

Bio-Rad Enters RNA-Seq Library Prep Market with Launch of the SEQuoia Complete Stranded RNA Library Prep Kit

/in , , , , , /by

SEQuoia Complete Stranded RNA Library Prep Kit is a high-performance kit that captures both long and short RNAs in a single library even from limited and low-quality samples. HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the SEQuoia Complete Stranded RNA Library Prep Kit, a novel approach to RNA-Seq […]

Read more →

Element Biosciences Raises $80M in Series B Financing to Accelerate Development of a New DNA Sequencing Platform

/in , /by

SAN DIEGO, Calif. — Element Biosciences today announced the close of a Series B financing round of $80.3 million, with participation from new investors Fidelity Management & Research Company and JS Capital LLC, as well as existing investors Foresite Capital and Venrock. To date, the company has raised a total of more than $100 million. Proceeds […]

Read more →

Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform

/in , /by

Company Raises $145 Million in Eighteen Months to Complete Development and Early Commercialization of Breakthrough DNA Sequencing Platform SAN DIEGO — Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announced it has raised an additional $60 million with the completion of its Series C financing. The funding round was led by Madrone […]

Read more →

BC Platforms partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers

/in , , , /by

BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante […]

Read more →

Single Cell Genome Sequencing Company BioSkryb Raises $11.5M in Seed Funding Round

/in , , , , , /by

DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The funding will accelerate BioSkryb’s product roadmap […]

Read more →